Pulling data from more than 5,400 opioid-related Twitter posts, scientists at the Biocomplexity Institute searched for common factors among the most highly shared content. They shared their findings with public health professionals from across the commonwealth at the 2018 Virginia Public Health & Healthcare Preparedness Academy in Roanoke.
Leaders at the Biocomplexity Institute of Virginia Polytechnic Institute and State University (Virginia Tech), in Blacksburg, Virginia, have been busy working on an exciting initiative: they have been developing an analytic modeling platform and simulation environment that make it possible to prepare for and prevent the spread of common infectious diseases such flu as well as rare diseases like Ebola and Zika.
A new study from the Biocomplexity Institute suggests that the debate around vaccination on social media may hinge more on different understandings of risk, responsibility, and credibility than any particular set of scientific data.
Biocomplexity Institute researchers are building an online network designed to help disease experts share information, identify warning signs of impending epidemics, and coordinate effective response strategies for ongoing outbreaks.
Once thought to affect mainly humans and livestock, Brucella bacteria are now being found in species scientists never expected. Previously unknown strains of the bacteria were recently discovered in African bullfrogs.
In addition to being difficult to treat, HIV leaves the body open to many other co-infections, including HPV, the most common sexually transmitted infection in the United States. Biocomplexity Institute researchers have developed a first-of-its-kind computational model to study how these two diseases impact each other's treatment and persistence.
As year-end activities ramp up, the flu is in full swing. In a season that’s often filled with social and economic pressures, the added price of influenza can be staggering: up to $87B in medical costs and lost productivity according to the latest Centers for Disease Control (CDC) statistics.
Antibacterial resistance is becoming an increasingly pressing problem in hospitals around the world. More and more species of bacteria are developing resistances to commonly used antibiotics, forcing an antibacterial arms race that often results in the death of patients.
Here’s what we know for sure. On the afternoon of Friday, 3 October 2014, Pyrros A. Telionis got a telephone call from the U.S. government’s Defense Threat Reduction Agency (DTRA). The voice on the phone was brisk and professional. And highly specific. Could Telionis provide, by 8 o’clock Monday morning, a list of the best places to build Ebola treatment centers in Liberia’s six southernmost counties?
BLACKSBURG, Va., April 30, 2015 – Public health officials are faced with a tough decision when vaccines are in short supply during an outbreak. How do they objectively decide who should be protected against disease?
BLACKSBURG, Va., Sept. 26, 2014 – The Ebola epidemic could claim hundreds of thousands of lives and infect more than 1.4 million people by the end of January, according to a statistical forecast released this week by the U.S. Centers for Disease Control and Prevention.
BLACKSBURG, Va, December 2, 2013 – Researchers at Virginia Bioinformatics Institute have recently returned from a trip halfway across the globe in the race to confront drug-resistant tuberculosis. As part of a week-long course in comparative genomics organized by researchers from the Broad Institute, senior bioscientist and computational biologist Rebecca Wattam trained participants on using the Pathosystems Resource Integration Center (PATRIC). PATRIC is a web-based portal that provides bacterial infectious disease researchers with analysis tools and comparative data. The course took place at the Kwazulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) in Durban, South Africa and involved participants from all over Africa.